6th International Conference
Acute Myeloid Leukemia "Molecular and Translational":
Advances in Biology and Treatment
Chairs: Bob Löwenberg, Hartmut Döhner, Martin Tallman

6th International Conference
Acute Myeloid Leukemia "Molecular and Translational":
Advances in Biology and Treatment
Information
ABOUT THE CONFERENCE:
The successful biannual ESH Conferences on acute myeloid leukemia (AML) have established themselves as scientific and educational programs at the interphase of molecular and biologic developments and clinical translation. Novel technological, molecular and immunologic approaches are rapidly creating novel insights into the biology and therapeutic perspectives of AML. The cutting-edge program of the conference will deal with the molecular and functional features of leukemic stem cells and their interaction with the microenvironment, the role of somatic and germ-line mutations and epigenetic alterations in the biology of AML, the genomics of leukemogenesis, advances in molecular diagnostics and developmental therapeutics with a focus on molecular and immunotherapeutic targeted therapeutics. Special attention will be given to the utility and promise of novel therapeutic agents.
This educational conference has been approved for 18 CME-CPD credit points by the European Board for Accreditation in Haematology (EBAH).
SCIENTIFIC TOPICS:
• Preleukemic hematopoiesis and clonal diversity
• Preleukemic conditions and predisposition
• Epigenetics
• MDS / Secondary leukemia
• Immune targeting
• Therapeutic targeting
Program
Read the final program!



